Skip to main content
. 2022 Apr 22;64:35–40. doi: 10.1016/j.breast.2022.04.004

Table 3.

Associations of binary markers with recurrence, ER, PR, her2 status and binary ki67 (above median 12 or below median 12), results from bivariate association analysis by the Fisher's exact test and logistic regression with adjustments for the effects of age and TILs density (>45% or≤45%).

Recurrence
No Yes P [1] Odds ratio [95% C.I.] p.adj [2]
N 54 13
CD8 > 70 (%) 17 (31.5) 9 (69.2) 0.024 1.54 [0.26, 8.83] 0.622
CD4 > 90 (%) 21 (38.9) 10 (76.9) 0.027 1.93 [0.35, 11.72] 0.449
CD68 > 50 (%) 13 (24.5) 10 (76.9) 0.001 5.79 [1.32, 31.56] 0.026
CD163 > 70 (%) 23 (42.6) 9 (69.2) 0.123 1.58 [0.37, 7.14] 0.532
FOXP3 > 6 (%) 24 (45.3) 11 (84.6) 0.014 2.84 [0.42, 23.94] 0.287
CD8/FOXP3 ratio >5 (%) 25 (47.2) 2 (15.4) 0.057 0.56 [0.06, 5.15] 0.587
CD68/CD163 ratio >0.46 (%)
22 (41.5)
12 (92.3)
0.001
16.73 [2.63, 338.79]
0.013
ER

negative
positive
P [1]
Odds ratio [95% C.I.]
p.adj [2]
N 13 54
CD8 > 70 (%) 9 (69.2) 17 (31.5) 0.024 0.14 [0.02, 0.80] 0.033
CD4 > 90 (%) 11 (84.6) 20 (37.0) 0.004 0.06 [0.01, 0.37] 0.006
CD68 > 50 (%) 4 (30.8) 19 (35.8) 1.00 2.32 [0.50, 12.76] 0.301
CD163 > 70 (%) 7 (53.8) 25 (46.3) 0.76 1.03 [0.25, 4.30] 0.969
FOXP3 > 6 (%) 11 (84.6) 24 (45.3) 0.014 0.15 [0.02, 0.86] 0.044
CD8/FOXP3 ratio >5 (%) 2 (15.4) 25 (47.2) 0.057 3.73 [0.63, 29.92] 0.161
CD68/CD163 ratio >0.46 (%)
9 (69.2)
25 (47.2)
0.218
0.38 [0.09, 1.46]
0.175
PR

negative
positive
P [1]
Odds ratio [95% C.I.]
p.adj [2]
N 16 51
CD8 > 70 (%) 10 (62.5) 16 (31.4) 0.039 0.23 [0.04, 1.08] 0.068
CD4 > 90 (%) 13 (81.2) 18 (35.3) 0.002 0.07 [0.01, 0.37] 0.003
CD68 > 50 (%) 5 (31.2) 18 (36.0) 1.00 2.12 [0.52, 10.09] 0.316
CD163 > 70 (%) 8 (50.0) 24 (47.1) 1.00 1.22 [0.34, 4.60] 0.758
FOXP3 > 6 (%) 13 (81.2) 22 (44.0) 0.011 0.17 [0.03, 0.81] 0.032
CD8/FOXP3 ratio >5 (%) 3 (18.8) 24 (48.0) 0.045 3.25 [0.68, 18.26] 0.148
CD68/CD163 ratio >0.46 (%)
11 (68.8)
23 (46.0)
0.154
0.38 [0.10, 1.29]
0.132
her2

negative
positive
P [1]
Odds ratio [95% C.I.]
p.adj [2]
N 48 12
CD8 > 70 (%) 18 (37.5) 8 (66.7) 0.104 0.93 [0.14, 5.65] 0.942
CD4 > 90 (%) 22 (45.8) 8 (66.7) 0.333 0.53 [0.06, 3.34] 0.511
CD68 > 50 (%) 16 (34.0) 6 (50.0) 0.334 0.77 [0.15, 3.48] 0.734
CD163 > 70 (%) 22 (45.8) 8 (66.7) 0.333 1.21 [0.26, 5.72] 0.803
FOXP3 > 6 (%) 24 (50.0) 10 (83.3) 0.052 1.54 [0.17, 14.26] 0.684
CD8/FOXP3 ratio >5 (%) 21 (43.8) 2 (16.7) 0.107 1.30 [0.11, 29.67] 0.837
CD68/CD163 ratio >0.46 (%)
23 (48.9)
7 (58.3)
0.748
0.98 [0.23, 4.15]
0.973
ki67 [3]

≤12
>12
P [1]
Odds ratio [95% C.I.]
p.adj [2]
N 33 29
CD8 > 70 (%) 6 (18.2) 20 (69.0) <0.001 6.05 [1.48, 27.67] 0.014
CD4 > 90 (%) 10 (30.3) 20 (69.0) 0.005 2.34 [0.61, 8.85] 0.206
CD68 > 50 (%) 7 (21.9) 16 (55.2) 0.009 2.58 [0.71, 9.67] 0.148
CD163 > 70 (%) 12 (36.4) 19 (65.5) 0.041 2.06 [0.62, 6.79] 0.23
FOXP3 > 6 (%) 10 (30.3) 24 (82.8) <0.001 6.28 [1.60, 27.61] 0.01
CD8/FOXP3 ratio >5 (%) 18 (54.5) 6 (20.7) 0.009 0.54 [0.13, 2.16] 0.381
CD68/CD163 ratio >0.46 (%) 13 (40.6) 19 (65.5) 0.073 2.37 [0.74, 7.94] 0.148